Jacqueline Barry

Chief Clinical Officer • CGT Catapult

Jacqueline joined Cell and Gene Therapy Catapult as Director of Regulatory Affairs and has since been promoted to Chief Clinical Officer. Prior to this, Jacqueline worked at the Scottish National Blood Transfusion Service in several senior regulatory and quality positions, the responsibility for which included designing the regulatory strategy for the Cellular Therapies developed by the Blood Transfusion Service acting as Responsible Person for Blood and Qualified Person for medicinal product release. Before that, she held a number of post-Doctoral academic posts at the University of Edinburgh, studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell-based medicinal products and therapies. 


Also speaking

Jordan Schecter

Vice President, Clinical Development Cellular Therapy Program • Janssen

Amandine Breton

Director MSAT & AST, Cell & Gene Therapies • Orchard Therapeutics

Vera Araujo

Senior Director, Business Development • Andelyn Biosciences

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.